Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it will effect a 1-for ...
Rise in number of surgical procedures and rise in use of plasma derived albumin in drug development drive the growth of the global albumin market. David Correa Allied Market Research +1 800-792-5285 ...